Unknown

Dataset Information

0

Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.


ABSTRACT: For most therapeutic proteins, a long serum half-life is desired. Studies have shown that decreased antigen binding at acidic pH can increase serum half-life. In this study, we aimed to investigate whether pH-dependent binding sites can be introduced into antigen binding crystallizable fragments of immunoglobulin G1 (Fcab). The C-terminal structural loops of an Fcab were engineered for reduced binding to the extracellular domain of human epidermal growth factor receptor 2 (Her2-ECD) at pH 6 compared to pH 7.4. A yeast-displayed Fcab-library was alternately selected for binding at pH 7.4 and non-binding at pH 6.0. Selected Fcab variants showed clear pH-dependent binding to soluble Her2-ECD (decrease in affinity at pH 6.0 compared to pH 7.4) when displayed on yeast. Additionally, some solubly expressed variants exhibited pH-dependent interactions with Her2-positive cells whereas their conformational and thermal stability was pH-independent. Interestingly, two of the three Fcabs did not contain a single histidine mutation but all of them contained variations next to histidines that already occurred in loops of the lead Fcab. The study demonstrates that yeast surface display is a valuable tool for directed evolution of pH-dependent binding sites in proteins.

SUBMITTER: Traxlmayr MW 

PROVIDER: S-EPMC4314675 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.

Traxlmayr Michael W MW   Lobner Elisabeth E   Hasenhindl Christoph C   Stadlmayr Gerhard G   Oostenbrink Chris C   Rüker Florian F   Obinger Christian C  

Biotechnology journal 20140801 8


For most therapeutic proteins, a long serum half-life is desired. Studies have shown that decreased antigen binding at acidic pH can increase serum half-life. In this study, we aimed to investigate whether pH-dependent binding sites can be introduced into antigen binding crystallizable fragments of immunoglobulin G1 (Fcab). The C-terminal structural loops of an Fcab were engineered for reduced binding to the extracellular domain of human epidermal growth factor receptor 2 (Her2-ECD) at pH 6 comp  ...[more]

Similar Datasets

| S-EPMC4432726 | biostudies-literature
| S-EPMC3365978 | biostudies-literature
| S-EPMC5693891 | biostudies-literature
| S-EPMC4423232 | biostudies-literature
| S-EPMC7288244 | biostudies-literature
| S-EPMC5800599 | biostudies-literature